Responding to the decision to remove two breast cancer drugs, trastuzumab emtansine (Kadcyla) and bevacizumab (Avastin), from the Cancer Drugs Fund,...
A US study of over 100,000 women diagnosed with DCIS between 1988 to 2011 has shown that while their overall risk of dying from breast cancer was low...
The study also found fertility concerns led a quarter of women who started tamoxifen to stop taking it before the recommended treatment period ended...
Responding to a new US study, published in the British Medical Journal, that suggests even light to moderate drinking among women was associated with...
